Cumberland drug company raises $3M seed round to develop cannabis-derived lung treatment
October 05, 2022 at 07:00 AM EDT
RS BioTherapeutics uses CBD from hemp to reduce lung inflammation from COPD, COVID-19 and other diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|